XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.2

Loss Per Common Share | 9 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Loss Per Common Share | Loss Per Common Share The following table summarizes the calculation of net loss and weighted average common shares and common equivalent shares outstanding for purposes of the computation of loss per share (in thousands, except share and per share data):
|  | Three Months Ended |  |  | Nine Months Ended |
|  | June 30, 2022 |  |  | June 30, 2021 |  |  | June 30, 2022 |  |  | June 30, 2021 |
Net loss |  | $ | (6,574 | ) |  | $ | (787 | ) |  | $ | (14,816 | ) |  | $ | (9,021 | )
Less: Loss allocable to unvested restricted stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Loss attributable to common shareholders for diluted earnings per share |  | $ | (6,574 | ) |  | $ | (787 | ) |  | $ | (14,816 | ) |  | $ | (9,021 | )
Weighted average number of common share equivalents: |  |  |  |  |  |  |  |  |  |  |  |
Common shares used in basic loss per share |  |  | 13,013,616 |  |  |  | 13,353,254 |  |  |  | 12,977,146 |  |  |  | 13,464,177 |
Common share equivalents outstanding related to stock options and RSUs |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total weighted average common shares and common share equivalents used in diluted loss per share |  |  | 13,013,616 |  |  |  | 13,353,254 |  |  |  | 12,977,146 |  |  |  | 13,464,177 |
Loss per share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.51 | ) |  | $ | (0.06 | ) |  | $ | (1.14 | ) |  | $ | (0.67 | )
Diluted |  | $ | (0.51 | ) |  | $ | (0.06 | ) |  | $ | (1.14 | ) |  | $ | (0.67 | )
For the calculation of diluted loss per share for the three and nine months ended June 30, 2022, 369,859 non-vested RSUs were excluded in the calculation of weighted average shares outstanding since their impact on diluted loss per share was antidilutive. For the calculation of diluted loss per share for the three and nine months ended June 30, 2021, 38,800 stock options and 331,999 non-vested RSUs were excluded in the calculation of weighted average shares outstanding since their impact on diluted loss per share was antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration